- Scientists studied untreated sleep apnea in laboratory animals.
- The study was done in a laboratory with mice.
- Oxygen dropped again and again during mouse sleep.
- Mice exposed to low oxygen died much earlier.
- Their hearts showed clear signs of early aging.
- Blood pressure increased and heart work worsened significantly.
- Blood vessels became less flexible and weaker.
- Researchers say this problem can shorten life.
- Early diagnosis and treatment are very important.
Difficult words
- apnea — a condition with pauses in breathing during sleepsleep apnea
- untreated — not given medical care or treatment
- oxygen — the gas animals and people need to breathe
- diagnosis — the process of finding what illness someone has
- vessel — a tube that carries blood in the bodyBlood vessels
- flexible — able to bend or change shape easily
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Have you ever had trouble sleeping?
- Would you see a doctor for sleep problems?
Related articles
Nasal spray reverses signs of brain aging in models
Researchers developed a nasal spray that delivers extracellular vesicles with microRNAs to the brain. In preclinical models it reduced inflammation, restored neuronal mitochondria and improved memory, but human tests are still needed.
Dopamine helps lock in new skills during sleep
A study from the University of Michigan finds that dopamine neurons become active during NREM sleep soon after a person learns a movement. Their activity, together with sleep spindles, strengthens motor memories and improves skills after sleep.
Exercise better than protein powder for older adults' muscle strength
A clinical trial in people aged 65 and over found that extra protein from whey capsules did not increase muscle strength after 24 weeks. Researchers say resistance exercise remains the most reliable way to improve strength.
New inflammatory pathway may explain some rheumatoid arthritis treatment failures
A Washington State University study found that a lesser-known TWEAK–Fn14 pathway can join with TNF to increase inflammation. Blocking Fn14 reduced this surge and may explain why some patients do not respond to TNF inhibitors.